News Glyphosate
Judge demands transparency about glyphosate
The European Food Safety Authority (EFSA) has to make the studies into the health risks associated with glyphosate public. That was decided by the European Court of Justice on Thursday 7 March.
The European Court of Justice demanded on Thursday 7 March that EFSA must show more transparency in its investigation into the health risks of plant protection products with glyphosate† According to the European court, the public interest outweighs the commercial interest of, for example, Bayer. EFSA now has 2 months to appeal.
However, the food safety organization has already announced that it will not make use of this. "This one pronunciation is important because it provides a guideline for how we should interpret European law when the public requests access to documents," said an EFSA spokesperson in a statement. Substance producers, on the other hand, cannot appeal because they are not directly involved. to be.
Renewal of license
The European license for the use of glyphosate was renewed for 2017 years in 5, mainly because the EFSA had ruled that glyphosate was not carcinogenic. This judgment was based in part on the unpublished investigations of the American company Monsanto, which has been a part of Bayer since 2018. At the time, the food safety organization said the publication of the studies could harm the industry's commercial and financial interests.
The Greens in the European Parliament disagreed and went to court, hoping to get the investigations public. They are therefore now upheld by the European Court of Justice. It is important here that the ruling applies directly and does not only apply to glyphosate; it concerns all protective equipment that will come to the market in the future, or that will have to apply for a new grant.
The full statement can be found here.
Kimberly Baker
© DCA Market Intelligence. This market information is subject to copyright. It is not permitted to reproduce, distribute, disseminate or make the content available to third parties for compensation, in any form, without the express written permission of DCA Market Intelligence.
